Your browser doesn't support javascript.
loading
Life-threatening hypophosphataemia secondary to zoledronic acid implementation in a middle-age patient who presented with advanced osteolysis in the course of multiple myeloma.
Radziszewski, Mikolaj; Karpilowska, Anna; Podgórska, Joanna; Ziólkowska, Anna; Popow, Michal.
Afiliação
  • Radziszewski M; Department of Internal Medicine and Endocrinology, University Clinical Centre, Medical University of Warsaw, Warsaw, Poland. m.a.radziszewski92@gmail.com.
  • Karpilowska A; Department of Internal Medicine and Endocrinology, University Clinical Centre, Medical University of Warsaw, Warsaw, Poland.
  • Podgórska J; 2nd Department of Clinical Radiology, University Clinical Centre, Medical University of Warsaw, Warsaw, Poland.
  • Ziólkowska A; Department of Internal Medicine and Endocrinology, University Clinical Centre, Medical University of Warsaw, Warsaw, Poland.
  • Popow M; Department of Internal Medicine and Endocrinology, University Clinical Centre, Medical University of Warsaw, Warsaw, Poland.
Endokrynol Pol ; 71(1): 100-101, 2020.
Article em En | MEDLINE | ID: mdl-31681977

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteólise / Hipofosfatemia / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteólise / Hipofosfatemia / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article